Results of the AiM, PLan, and act on LIFestYles (AMPLIFY) Weight Loss Intervention Among Survivors of Obesity-Related Cancers: A Randomized Clinical Trial
Journal of the National Comprehensive Cancer Network · 2026-07 · 24 (7)
DOI: 10.6004/jnccn.2026.7012 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Journal of the National Comprehensive Cancer Network, 2026-07. Verfasst von Wendy Demark-Wahnefried und 12 weiteren Autor:innen. Beteiligte Einrichtung: 1O'Neal Comprehensive Cancer Center at the University of Alabama at Birmingham, Birmingham, AL. Hauptthemen laut MEDLINE: Obesity, Cancer Survivors, Neoplasms, Weight Reduction Programs. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NIDDK NIH HHS.
Abstract (Originalsprache)
Background: The number of cancer survivors is growing rapidly, and >70% are overweight or obese. Given their increased risk for obesity-related conditions (eg, cardiovascular disease, second malignancies), weight-loss interventions are a priority for this population, yet few have access. Patients and Methods: We conducted a 2-arm, single-blinded, randomized controlled trial to test whether a 24-week, fully automated, web-based diet intervention would significantly improve body weight and other health-related outcomes compared with a waitlist control among cancer survivors. The AiM, PLan, and act on LIFestYles (AMPLIFY) diet intervention offered serialized, tailored guidance to achieve a 0.5 kg per week weight loss and improve diet quality. Survivors of 1 of 9 obesity-related cancers with >70% 5-year survival, aged ≥50 years, and with a body mass index of 25 to
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- 1O'Neal Comprehensive Cancer Center at the University of Alabama at Birmingham, Birmingham, AL.
- 2Clinical and Diagnostic Sciences, University of Alabama at Birmingham, Birmingham, AL.
- 3Department of Medicine, University of Alabama at Birmingham, Birmingham, AL.
- 4Department of Health Behavior, University of Alabama at Birmingham, Birmingham, AL.
- 5Department of Preventive Medicine, University of Tennessee Health Science Center, Memphis, TN.
- 6Department of Health Services Administration, University of Alabama at Birmingham, Birmingham, AL.
Förderung
- NCI NIH HHS
- NIDDK NIH HHS
Zitieren
APA
Demark-Wahnefried, W., Pisu, M., Pekmezi, D. W., Martin, M. Y., Fontaine, K. R., Oster, R. A., Ivankova, N. V., Kaur, H., Schoenberger-Godwin, Y. M., Farrell, D., Kenzik, K., Waugaman, K. J., & Rogers, L. Q. (2026). Results of the AiM, PLan, and act on LIFestYles (AMPLIFY) Weight Loss Intervention Among Survivors of Obesity-Related Cancers: A Randomized Clinical Trial. Journal of the National Comprehensive Cancer Network, 24(7). https://doi.org/10.6004/jnccn.2026.7012
Vancouver
Demark-Wahnefried W, Pisu M, Pekmezi DW, Martin MY, Fontaine KR, Oster RA, et al. Results of the AiM, PLan, and act on LIFestYles (AMPLIFY) Weight Loss Intervention Among Survivors of Obesity-Related Cancers: A Randomized Clinical Trial. Journal of the National Comprehensive Cancer Network. 2026;24(7). doi:10.6004/jnccn.2026.7012
BibTeX
@article{DemarkWahnefried2026,
author = {Demark-Wahnefried, Wendy and Pisu, Maria and Pekmezi, Dori W and Martin, Michelle Y and Fontaine, Kevin R and Oster, Robert A and Ivankova, Nataliya V and Kaur, Harleen and Schoenberger-Godwin, Yu-Mei and Farrell, David and Kenzik, Kelly and Waugaman, Kaitlyn J and Rogers, Laura Q},
title = {Results of the AiM, PLan, and act on LIFestYles (AMPLIFY) Weight Loss Intervention Among Survivors of Obesity-Related Cancers: A Randomized Clinical Trial},
journal = {Journal of the National Comprehensive Cancer Network},
year = {2026},
volume = {24},
number = {7},
doi = {10.6004/jnccn.2026.7012}
}
EUVIMED